Principles, approaches, and challenges for predicting protein aggregation rates and shelf life.
暂无分享,去创建一个
William F Weiss | William F. Weiss | Christopher J Roberts | C. Roberts | Teresa M Young | T. M. Young
[1] Michail Yu. Lobanov,et al. Prediction of Amyloidogenic and Disordered Regions in Protein Chains , 2006, PLoS Comput. Biol..
[2] Michael J. Pikal,et al. Protein Stability During Freezing: Separation of Stresses and Mechanisms of Protein Stabilization , 2007, Pharmaceutical development and technology.
[3] William F. Weiss,et al. Nonnative protein polymers: structure, morphology, and relation to nucleation and growth. , 2007, Biophysical journal.
[4] T. Arakawa,et al. Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions. , 1996, Analytical biochemistry.
[5] C. Royer,et al. Exploring the temperature-pressure phase diagram of staphylococcal nuclease. , 1999, Biochemistry.
[6] Mark Durst,et al. Scan-rate-dependent melting transitions of interleukin-1 receptor (type II): elucidation of meaningful thermodynamic and kinetic parameters of aggregation acquired from DSC simulations. , 2005, Journal of the American Chemical Society.
[7] Regina M. Murphy,et al. Probing the Kinetics of β-Amyloid Self-Association , 2000 .
[8] A. Arabshahi,et al. [6] Second virial coefficient as predictor in protein crystal growth. , 1997, Methods in enzymology.
[9] John F. Carpenter,et al. Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.
[10] D. Milardi,et al. An alternative approach in the structure-based predictions of the thermodynamics of protein unfolding. , 1997, Biophysical chemistry.
[11] R. Murphy,et al. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. , 2001, Biophysical journal.
[12] D. Baker,et al. Native protein sequences are close to optimal for their structures. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] Sandeep Nema,et al. Protein Structural Conformation and Not Second Virial Coefficient Relates to Long-Term Irreversible Aggregation of a Monoclonal Antibody and Ovalbumin in Solution , 2006, Pharmaceutical Research.
[14] A. Lenhoff,et al. Molecular origins of osmotic second virial coefficients of proteins. , 1998, Biophysical journal.
[15] V. Uversky,et al. Conformational Prerequisites for α-Lactalbumin Fibrillation† , 2002 .
[16] B. Kurganov. Kinetics of heat aggregation of proteins. , 1998, Biochemistry. Biokhimiia.
[17] Ritu S. Sharma,et al. Formation of amyloid fibrils via longitudinal growth of oligomers. , 2007, Biochemistry.
[18] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[19] J. Kim,et al. Predicting Solvent and Aggregation Effects of Peptides Using Group Contribution Calculations , 2006, Biotechnology progress.
[20] L. Margulis,et al. Aggregation of Recombinant Bovine Granulocyte Colony Stimulating Factor in Solution , 2002, Journal of protein chemistry.
[21] J. Ralston,et al. Solution Behavior of IFN-β-1a: An Empirical Phase Diagram Based Approach , 2005 .
[22] David Eisenberg,et al. The structural biology of protein aggregation diseases: Fundamental questions and some answers. , 2006, Accounts of chemical research.
[23] W. Gombotz,et al. Minimization of recombinant human Flt3 ligand aggregation at the Tm plateau: a matter of thermal reversibility. , 1999, Biochemistry.
[24] J. Philo. Is any measurement method optimal for all aggregate sizes and types? , 2006, The AAPS Journal.
[25] Fumio Oosawa,et al. Thermodynamics of the polymerization of protein , 1975 .
[26] E. Kaler,et al. Patterns of protein–protein interactions in salt solutions and implications for protein crystallization , 2007, Protein science : a publication of the Protein Society.
[27] G. Gao,et al. A molecular-thermodynamic model for the interactions between globular proteins in aqueous solutions: applications to bovine serum albumin (BSA), lysozyme, alpha-chymotrypsin, and immuno-gamma-globulins (IgG) solutions. , 2006, Journal of colloid and interface science.
[28] V. Uversky,et al. Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.
[29] W. Wang,et al. Lyophilization and development of solid protein pharmaceuticals. , 2000, International journal of pharmaceutics.
[30] Abraham M Lenhoff,et al. Rapid measurement of protein osmotic second virial coefficients by self-interaction chromatography. , 2002, Biophysical journal.
[31] A George,et al. Predicting protein crystallization from a dilute solution property. , 1994, Acta crystallographica. Section D, Biological crystallography.
[32] Theodore W Randolph,et al. High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics. , 2008, Journal of pharmaceutical sciences.
[33] William F. Weiss,et al. Nucleation, growth, and activation energies for seeded and unseeded aggregation of alpha-chymotrypsinogen A. , 2008, Biochemistry.
[34] Francesc X. Avilés,et al. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinform..
[35] R. Murphy,et al. Misbehaving proteins : protein (mis)folding, aggregation, and stability , 2006 .
[36] J. Hofrichter,et al. Kinetics of sickle hemoglobin polymerization. I. Studies using temperature-jump and laser photolysis techniques. , 1985, Journal of molecular biology.
[37] S. Shire,et al. A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation , 2006, The AAPS Journal.
[38] S. Sandler,et al. Correlation between the Osmotic Second Virial Coefficient and the Solubility of Proteins , 2001, Biotechnology progress.
[39] Wayne R. Gombotz,et al. Interleukin-1 Receptor (IL-1R) Liquid Formulation Development Using Differential Scanning Calorimetry , 1998, Pharmaceutical Research.
[40] L. Stryer,et al. Cooperative polymerization reactions. Analytical approximations, numerical examples, and experimental strategy. , 1986, Biophysical journal.
[41] Wei Wang,et al. Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.
[42] Joleen T White,et al. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. , 2004, Biochemistry.
[43] Flavio Seno,et al. Aggregation of natively folded proteins: a theoretical approach , 2007 .
[44] Klein,et al. Universal reaction-limited colloid aggregation. , 1990, Physical review. A, Atomic, molecular, and optical physics.
[45] Salvador Ventura,et al. Mutagenesis of the central hydrophobic cluster in Aβ42 Alzheimer's peptide , 2006 .
[46] Study on osmotic pressures for aqueous lysozyme and alpha-chymotrypsin-electrolyte solutions with two Yukawa potentials. , 2002, Journal of colloid and interface science.
[47] E. Kaler,et al. Measurement of Polydisperse Colloidal Suspensions with quasielastic light scattering , 1991 .
[48] Structural characterization of bovine granulocyte colony stimulating factor: effect of temperature and pH. , 2003, Journal of pharmaceutical sciences.
[49] Michele Vendruscolo,et al. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.
[50] A. Hernández-Arana,et al. Effect of irreversibility on the thermodynamic characterization of the thermal denaturation of Aspergillus saitoi acid proteinase. , 1995, The Biochemical journal.
[51] R. Murphy,et al. Kinetics of inhibition of β-amyloid aggregation by transthyretin , 2006 .
[52] J. King,et al. Probing folding and fluorescence quenching in human γD crystallin Greek key domains using triple tryptophan mutant proteins , 2004, Protein science : a publication of the Protein Society.
[53] A. Fersht,et al. Negative activation enthalpies in the kinetics of protein folding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[54] L M Amzel,et al. Loss of translational entropy in binding, folding, and catalysis , 1997, Proteins.
[55] J. Prausnitz,et al. Interactions of lysozyme in guanidinium chloride solutions from static and dynamic light-scattering measurements. , 2005, Biotechnology and bioengineering.
[56] A. Esteras-Chopo,et al. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. , 2007, Journal of molecular biology.
[57] C. Roberts,et al. A quasichemical approach for protein-cluster free energies in dilute solution. , 2007, The Journal of chemical physics.
[58] John P. Gabrielson,et al. Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity. , 2007, Journal of pharmaceutical sciences.
[59] J. Carpenter,et al. A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20. , 2002, Journal of pharmaceutical sciences.
[60] D. Svergun,et al. Absence of equilibrium cluster phase in concentrated lysozyme solutions , 2008, Proceedings of the National Academy of Sciences.
[61] C. Roberts,et al. Non-native aggregation of alpha-chymotrypsinogen occurs through nucleation and growth with competing nucleus sizes and negative activation energies. , 2007, Biochemistry.
[62] M. A. Larson,et al. Transient and steady state size distributions in continuous mixed suspension crystallizers , 1962 .
[63] Christopher J Roberts,et al. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life. , 2003, Journal of pharmaceutical sciences.
[64] A G Murzin,et al. SCOP: a structural classification of proteins database for the investigation of sequences and structures. , 1995, Journal of molecular biology.
[65] Correlation and Prediction of Osmotic Pressures for Aqueous Bovine Serum Albumin-NaCl Solutions Based on Two Yukawa Potentials. , 2001, Journal of colloid and interface science.
[66] J. L. López-Lacomba,et al. Differential scanning calorimetry of the irreversible thermal denaturation of thermolysin. , 1988, Biochemistry.
[67] W. J. Becktel,et al. Protein stability curves , 1987, Biopolymers.
[68] M. Manning,et al. Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation. , 2005, Journal of pharmaceutical sciences.
[69] M. Cromwell,et al. Benzyl alcohol-induced destabilization of interferon-gamma: a study by hydrogen-deuterium isotope exchange. , 2004, Journal of pharmaceutical sciences.
[70] D. Kalonia,et al. Determination of second virial coefficient of proteins using a dual-detector cell for simultaneous measurement of scattered light intensity and concentration in SEC-HPLC. , 2004, Biophysical journal.
[71] Amedeo Caflisch,et al. Computational models for the prediction of polypeptide aggregation propensity. , 2006, Current opinion in chemical biology.
[72] A. Benito,et al. Pressure- and temperature-induced unfolding studies: thermodynamics of core hydrophobicity and packing of ribonuclease A , 2006, Biological chemistry.
[73] A. Rosenberg,et al. Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.
[74] Daniel T Gillespie,et al. Stochastic simulation of chemical kinetics. , 2007, Annual review of physical chemistry.
[75] C. R. Middaugh,et al. Silicone oil induced aggregation of proteins. , 2005, Journal of pharmaceutical sciences.
[76] Theodore W Randolph,et al. Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations. , 2002, Journal of pharmaceutical sciences.
[77] V. Hilser,et al. The heat capacity of proteins , 1995, Proteins.
[78] J. King,et al. Aggregation of granulocyte‐colony stimulating factor in vitro involves a conformationally altered monomeric state , 2005, Protein science : a publication of the Protein Society.
[79] D. Baker,et al. The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[80] A. Cavalli,et al. The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates , 2004, Protein science : a publication of the Protein Society.
[81] P. C. Hiemenz,et al. Principles of colloid and surface chemistry , 1977 .
[82] Henry Eyring,et al. Conformation Changes of Proteins , 1954 .
[83] Christopher M. Dobson,et al. Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.
[84] T. Ban,et al. Critical balance of electrostatic and hydrophobic interactions is required for beta 2-microglobulin amyloid fibril growth and stability. , 2005, Biochemistry.
[85] A. Grillo,et al. Conformational origin of the aggregation of recombinant human factor VIII. , 2001, Biochemistry.
[86] Michele Vendruscolo,et al. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.
[87] A. Randolph. The mixed suspension, mixed product removal crystallizer as a concept in crystallizer design , 1965 .
[88] H. Levine. Quantification of beta-sheet amyloid fibril structures with thioflavin T. , 1999, Methods in enzymology.
[89] D. Volkin,et al. Degradative covalent reactions important to protein stability. , 1997, Methods in molecular biology.
[90] J. Carpenter,et al. Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[91] Robert A. Grothe,et al. Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.
[92] J. M. Sanchez-Ruiz,et al. Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry. , 1992, Biophysical journal.
[93] F. Ferrone,et al. Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.
[94] M. Manning,et al. Aggregation of recombinant human interferon gamma: kinetics and structural transitions. , 1998, Journal of pharmaceutical sciences.
[95] L. Serrano,et al. Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.
[96] C Russell Middaugh,et al. Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice. , 2006, Journal of pharmaceutical sciences.
[97] G. McRae,et al. A three-stage kinetic model of amyloid fibrillation. , 2007, Biophysical journal.
[98] Christopher J Roberts,et al. Non‐native protein aggregation kinetics , 2007, Biotechnology and bioengineering.
[99] Kerson Huang. Statistical Mechanics, 2nd Edition , 1963 .
[100] T. Nicotera,et al. Linear quantitation of Aβ aggregation using Thioflavin T: Reduction in fibril formation by colostrinin , 2007, Journal of Neuroscience Methods.
[101] C. Dobson,et al. Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.
[102] Amedeo Caflisch,et al. Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences , 2005, Protein science : a publication of the Protein Society.
[103] W. Stockmayer,et al. Information on Polydispersity and Branching from Combined Quasi-Elastic and Intergrated Scattering , 1980 .
[104] Christopher J Roberts,et al. A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding. , 2007, The journal of physical chemistry. B.
[105] P. Privalov. Stability of proteins: small globular proteins. , 1979, Advances in protein chemistry.
[106] D. Milardi,et al. Extended theoretical analysis of irreversible protein thermal unfolding. , 1994, Biophysical chemistry.
[107] D. I. Wang,et al. Polymerization mechanism of polypeptide chain aggregation. , 1997, Biotechnology and bioengineering.
[108] W. William Wilson,et al. Relation between the solubility of proteins in aqueous solutions and the second virial coefficient of the solution , 1999 .
[109] J. Hofrichter,et al. Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism. , 1985, Journal of molecular biology.
[110] Fabrizio Chiti,et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[111] B. Chang,et al. Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[112] Dennis E. Koppel,et al. Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants , 1972 .
[113] C. Sauber,et al. Comparison of selected analytical techniques for protein sizing, quantitation and molecular weight determination. , 2004, Journal of biochemical and biophysical methods.
[114] K. Breslauer,et al. Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves , 1987, Biopolymers.
[115] Theodore W Randolph,et al. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony‐stimulating factor , 2003, Protein science : a publication of the Protein Society.
[116] W. van Osdol,et al. Calorimetrically determined dynamics of complex unfolding transitions in proteins. , 1990, Annual review of biophysics and biophysical chemistry.
[117] D. Wuttke,et al. High concentration formulations of recombinant human interleukin-1 receptor antagonist: I. Physical characterization. , 2008, Journal of pharmaceutical sciences.
[118] J. Carpenter,et al. High‐pressure studies of aggregation of recombinant human interleukin‐1 receptor antagonist: Thermodynamics, kinetics, and application to accelerated formulation studies , 2005, Protein science : a publication of the Protein Society.
[119] D. Vaux,et al. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. , 2002, Biochemistry.
[120] Thomas M Truskett,et al. Coarse-grained strategy for modeling protein stability in concentrated solutions. , 2005, Biophysical journal.
[121] Regina M Murphy,et al. Reconsidering the mechanism of polyglutamine peptide aggregation. , 2007, Biochemistry.
[122] Huub Schellekens,et al. Bioequivalence and the immunogenicity of biopharmaceuticals , 2002, Nature Reviews Drug Discovery.
[123] M. Pikal,et al. Solid state chemistry of proteins: II. The correlation of storage stability of freeze-dried human growth hormone (hGH) with structure and dynamics in the glassy solid. , 2008, Journal of pharmaceutical sciences.
[124] U Aebi,et al. Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.
[125] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[126] Wei Wang,et al. Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.
[127] R. Golbik,et al. Effect of environmental conditions on aggregation and fibril formation of barstar , 2003, European Biophysics Journal.
[128] D Baker,et al. Topology, stability, sequence, and length: defining the determinants of two-state protein folding kinetics. , 2000, Biochemistry.
[129] J L Cleland,et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.
[130] W Wang,et al. Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.
[131] Murphy,et al. Static and dynamic light scattering of biological macromolecules: what can we learn? , 1997, Current opinion in biotechnology.
[132] A. Doig. Peptide inhibitors of beta-amyloid aggregation. , 2007, Current opinion in drug discovery & development.
[133] G. Winter,et al. Thermodynamically stable aggregation-resistant antibody domains through directed evolution. , 2008, Journal of molecular biology.
[134] Melissa S Kosinski-Collins,et al. In vitro unfolding, refolding, and polymerization of human γD crystallin, a protein involved in cataract formation , 2003, Protein science : a publication of the Protein Society.
[135] E. Powers,et al. The kinetics of nucleated polymerizations at high concentrations: amyloid fibril formation near and above the "supercritical concentration". , 2006, Biophysical journal.
[136] Theodore W Randolph,et al. Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonist. , 2005, Journal of pharmaceutical sciences.
[137] S. Tobler,et al. Structural features of interferon‐γ aggregation revealed by hydrogen exchange , 2002 .
[138] Fred Jacobson,et al. Protein aggregation and bioprocessing , 2006, The AAPS Journal.
[139] J. M. Sanchez-Ruiz,et al. Lower kinetic limit to protein thermal stability: A proposal regarding protein stability in vivo and its relation with misfolding diseases , 2000, Proteins.
[140] G. Barone,et al. Prediction of the heat capacity change on thermal denaturation of globular proteins , 1998 .
[141] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[142] L. Serrano,et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.
[143] Arieh Ben-Naim,et al. Statistical Thermodynamics for Chemists and Biochemists , 1992, Springer US.
[144] D. Pochan,et al. Thermally reversible hydrogels via intramolecular folding and consequent self-assembly of a de novo designed peptide. , 2003, Journal of the American Chemical Society.
[145] R. Murphy,et al. Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context. , 2005, Biochemistry.
[146] Silvio C. E. Tosatto,et al. The PASTA server for protein aggregation prediction. , 2007, Protein engineering, design & selection : PEDS.
[147] J. Prausnitz,et al. Molecular thermodynamics for some applications in biotechnology , 2003 .
[148] A. Fink,et al. Fibrillation of human insulin A and B chains. , 2006, Biochemistry.
[149] C. Roberts. Kinetics of Irreversible Protein Aggregation: Analysis of Extended Lumry−Eyring Models and Implications for Predicting Protein Shelf Life , 2003 .
[150] S. Yoshioka,et al. Is Stability Prediction Possible for Protein Drugs? Denaturation Kinetics of β- Galactosidase in Solution , 1994, Pharmaceutical Research.
[151] Christopher M. Dobson,et al. Amyloid fibrils from muscle myoglobin , 2001, Nature.
[152] H. Lekkerkerker,et al. Predicting the gas-liquid critical point from the second virial coefficient , 2000 .
[153] Christopher M Dobson,et al. Principles of protein folding, misfolding and aggregation. , 2004, Seminars in cell & developmental biology.
[154] S. Yoshioka,et al. Inactivation Kinetics of Enzyme Pharmaceuticals in Aqueous Solution , 1991, Pharmaceutical Research.
[155] A. Plückthun,et al. Stability engineering of antibody single-chain Fv fragments. , 2001, Journal of molecular biology.